Dr. Lin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3655 Lomita Blvd
Ste 101
Torrance, CA 90505Phone+1 310-543-1677Fax+1 310-543-9838
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1997 - 2000
Albert Einstein College of MedicineClass of 1997
Certifications & Licensure
CA State Medical License 2000 - 2025
FL State Medical License 1999 - 2002
MN State Medical License 1998 - 2000- National Board of Physicians and Surgeons Internal Medicine
Publications & Presentations
PubMed
- 21 citationsDaratumumab plus RVd for newly diagnosed multiple myeloma: final analysis of the safety run-in cohort of GRIFFIN.Peter M. Voorhees, Cesar Rodriguez, Brandi Reeves, Nitya Nathwani, Luciano J. Costa
Blood Advances. 2021-02-23 - 390 citationsDaratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trialPeter M. Voorhees, Jonathan L. Kaufman, Jacob P. Laubach, Douglas W. Sborov, Brandi Reeves
Blood. 2020-08-20 - 53 citationsDaratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA studyHabte A. Yimer, Jason M. Melear, Edward A. Faber, William I. Bensinger, John M. Burke
British Journal of Haematology. 2019-05-01
Grant Support
- Monoclonal Antibody Therapy In B-Cell CLL.National Cancer Institute2005–2008
- A Phase I Study Of Single Agent Flavopiridol In B-Cell *National Cancer Institute2006–2007
- A Phase I Study Of The AKT Inhibitor 17-AAG In CLLNational Cancer Institute2005–2006
- A Novel Dosing Schedule Of Flavopiridol In CLLNational Cancer Institute2005–2006
- A Phase I Study Of Flavopiridol, Fludarabine And RituximabNational Center For Research Resources2005
- A Dose Escalation Study Of Flavopiridol (Nsc 649890)National Center For Research Resources2004–2005
- Phase I Study Of Flavopiridol, Fludarabine And RituximabNational Center For Research Resources2004
- Monoclonal Antibody Therapy In B-Cell CLLNational Cancer Institute2004
Other Languages
- Chinese (Mandarin), Japanese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
